Johnson & Johnson FDA approval ICOTYDE Boom Explained
Can Johnson & Johnson’s FDA approval of ICOTYDE really shift the psoriasis market enough to move a $575 billion healthcare giant? Maik Kemper Editor in…
Moderna Patent Settlement +11.3% Surge: Is the $2.25B Hit Worth the Clarity?
Does Moderna’s billion‑dollar patent peace deal finally clear the runway for its mRNA pipeline—or just cap the upside? Moderna Patent Settlement: Why Wall Street Is…